Early Diagnosis and Treatment of Gastrointestinal Cancer by Nanotechnology Applications

Maged Naser, Mohamed M. Nasr, Lamia H. Shehata

Abstract


Propels in nanotechnology have opened new wildernesses in the diagnosis and therapy of malignant growth. Nanoparticle-based innovation works on the accuracy of cancer diagnosis when joined with imaging, as well as the precision of medication target delivery, with less incidental effects. Streamlined nano systems enjoy showed benefits in many fields, including upgraded specificity of detection, diminished toxicity of medications, improved impact of contrast agents, and high level diagnosis and treatment of gastrointestinal (GI) cancers. In this review, we sum up the ongoing nanotechnologies in diagnosis and therapy of GI malignant growths. The improvement of nanotechnology will prompt customized approaches for early diagnosis and therapy of GI malignant growths.


Keywords


Nano devices; Nanoparticles; Gastrointestinal cancer; Diagnosis; Therapeutics.

Full Text:

PDF

References


-Sung, Hyuna, et al. "Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries." CA: a cancer journal for clinicians 71.3 (2021): 209-249.

-Liu, Zhenqiu, et al. "The disparities in gastrointestinal cancer incidence among Chinese populations in Shanghai compared to Chinese immigrants and indigenous non‐Hispanic white populations in Los Angeles, USA." International Journal of Cancer 146.2 (2020): 329-340.

-Siegel, Rebecca L., et al. "Cancer statistics, 2021." Ca Cancer J Clin 71.1 (2021): 7-33.

-Liu, Shanhu, et al. "Structural effects of Fe3O4 nanocrystals on peroxidase‐like activity." Chemistry–A European Journal 17.2 (2011): 620-625.

-Barreto, José A., et al. "Nanomaterials: applications in cancer imaging and therapy." Advanced materials 23.12 (2011): H18-H40.

-Laroui, Hamed, et al. "Nanomedicine in GI." American Journal of Physiology-Gastrointestinal and Liver Physiology 300.3 (2011): G371-G383.

-Service, Robert F. "Nanotechnology grows up." (2004): 1732-1734.

-Lamprecht, Alf, Ulrich Schäfer, and Claus-Michael Lehr. "Size-dependent bio adhesion of micro-and nano particulate carriers to the inflamed colonic mucosa." Pharmaceutical research 18 (2001): 788-793.

-Biabanikhankahdani, Roya, et al. "A dual bioconjugated virus-like nanoparticle as a drug delivery system and comparison with a pH-responsive delivery system." Nanomaterials 8.4 (2018): 236.

-Acharya, Sarbari, Fahima Dilnawaz, and Sanjeeb K. Sahoo. "Targeted epidermal growth factor receptor nanoparticle bio conjugates for breast cancer therapy." Biomaterials 30.29 (2009): 5737-5750.

-Lacoeuille, Franck, et al. "Lipid nano capsules for intracellular drug delivery of anticancer drugs." Journal of nanoscience and nanotechnology 7.12 (2007): 4612-4617.

-Dittgen, M., and B. Herbst. "Zeta potential – fundamentals, measurement methods and application to pharmacy." Die Pharmazie 42.10 (1987): 641-656.

-Otsuka, Hidenori, Yukio Nagasaki, and Kazunori Kataoka. "PEGylated nanoparticles for biological and pharmaceutical applications." Advanced drug delivery reviews 55.3 (2003): 403-419.

-Hörter, D., and J. B. Dressman. "Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract." Advanced drug delivery reviews 46.1-3 (2001): 75-87.

-Hua, Susan, et al. "Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue." Nanomedicine: nanotechnology, biology and medicine 11.5 (2015): 1117-1132.

-Moss, Darren Michael, et al. "The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery." Expert Review of Gastroenterology & Hepatology 12.3 (2018): 223-236.

-Reinholz, Jonas, Katharina Landfester, and Volker Mailänder. "The challenges of oral drug delivery via nano carriers." Drug delivery 25.1 (2018): 1694-1705.

-Lin, H. C., et al. "646 Akkermans LM, Loening-Baucke V; AMS Task Force Committee on Gastrointestinal 647 Transit. Measurement of gastrointestinal transit." Dig Dis Sci 50.989-1004 (2005): 648.

-Hua, Susan. "Advances in oral drug delivery for regional targeting in the gastrointestinal tract-influence of physiological, pathophysiological and pharmaceutical factors." Frontiers in pharmacology 11 (2020): 524.

-Bellmann, Susann, et al. "Mammalian gastrointestinal tract parameters modulating the integrity, surface properties, and absorption of food‐relevant nanomaterials." Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 7.5 (2015): 609-622.

-Sykes, Paul D., et al. "Nanotechnology advances in upper gastrointestinal, liver and pancreatic cancer." Expert Review of Gastroenterology & Hepatology 6.3 (2012): 343-356.

-Ishiyama, Koichi, et al. "Visualization of lymphatic basin from the tumor using magnetic resonance lymphography with superparamagnetic iron oxide in patients with thoracic esophageal cancer." Journal of computer assisted tomography 30.2 (2006): 270-275.

-Pultrum, B. B., et al. "Detection of lymph node metastases with ultra small superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility study." Cancer Imaging 9.1 (2009): 19.

-Tokuhara, Takaya, et al. "Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO): diagnostic performance in post-contrast images using new diagnostic criteria." Gastric Cancer 11 (2008): 194-200.

-Reimer, P., and B. Tom bach. "Hepatic MRI with SPIO: detection and characterization of focal liver lesions." European radiology 8 (1998): 1198-1204.

-Whitehead, Kathryn A., Robert Langer, and Daniel G. Anderson. "Knocking down barriers: advances in siRNA delivery." Nature reviews Drug discovery 8.2 (2009): 129-138.

-Panyam, Jayanth, and Vinod Labhasetwar. "Biodegradable nanoparticles for drug and gene delivery to cells and tissue." Advanced drug delivery reviews 55.3 (2003): 329-347.

-Coenegrachts, K., et al. "Evaluation of peri-tumoral vessels surrounding colorectal liver metastases after intravenous injection of extruded magnetoliposomes in rats: correlation with 3T MRI and histopathology." Journal of the Belgian Society of Radiology 93.2 (2010): 87-91.

-Nikezić, Ana V. Vujačić, Aleksandra M. Bondžić, and Vesna M. Vasić. "Drug delivery systems based on nanoparticles and related nanostructures." European Journal of Pharmaceutical Sciences 151 (2020): 105412.

-Chouhan, Raghuraj Singh, et al. "Magnetic nanoparticles—A multifunctional potential agent for diagnosis and therapy." Cancers 13.9 (2021): 2213.

-Widder, Kenneth J., Andrew E. Senyei, and Dante G. Scarpelli. "Magnetic microspheres: a model system for site specific drug delivery in vivo." Proceedings of the Society for Experimental Biology and Medicine 158.2 (1978): 141-146.

-Choi, Jin-Young, et al. "Detection of hepatic metastasis: manganese-and ferucarbotran-enhanced MR imaging." European journal of radiology 60.1 (2006): 84-90.

-Wang, Yi-Xiang J., Shahid M. Hussain, and Gabriel P. Krestin. "Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging." European radiology 11 (2001): 2319-2331.

-Kumagai, Hironori, et al. "Multifunctional nanobeacon for imaging Thomsen‐Friedenreich antigen‐associated colorectal cancer." International journal of cancer 132.9 (2013): 2107-2117.

-Fortuin, Ansje S., et al. "Ultra‐small superparamagnetic iron oxides for metastatic lymph node detection: Back on the block." Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 10.1 (2018): e1471.

-Thian, Yee Liang, Angela M. Riddell, and Dow-Mu Koh. "Liver-specific agents for contrast-enhanced MRI: role in oncological imaging." Cancer imaging 13.4 (2013): 567.

-Huertas, Andres, et al. "Preoperative radiotherapy for rectal cancer: target volumes." Cancer Radiotherapie: Journal de la Societe Francaise de Radiotherapie Oncologique 17.5-6 (2013): 477-485.

-Weissleder, Ralph. "Liver MR imaging with iron oxides: toward consensus and clinical practice." Radiology 193.3 (1994): 593-595.

-Reimer, Peter, and Thomas Balzer. "Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications." European radiology 13 (2003): 1266-1276.

-Cuenca, Alex G., et al. "Emerging implications of nanotechnology on cancer diagnostics and therapeutics." Cancer 107.3 (2006): 459-466.

-He, Yue, et al. "In situ spectral imaging of marker proteins in gastric cancer with near-infrared and visible quantum dots probes." Talanta 85.1 (2011): 136-141.

-Peng, Chun-Wei, et al. "Quantum-dots based simultaneous detection of multiple biomarkers of tumor stromal features to predict clinical outcomes in gastric cancer." Biomaterials 33.23 (2012): 5742-5752.

-Feng, Taotao, Yue Wang, and Xiuwen Qiao. "Recent advances of carbon nanotubes‐based electrochemical immunosensors for the detection of protein cancer biomarkers." Electroanalysis 29.3 (2017): 662-675.

-Lewinski, Nastassja, Vicki Colvin, and Rebekah Drezek. "Cytotoxicity of nanoparticles." small 4.1 (2008): 26-49.

-Zanello, Laura P., et al. "Bone cell proliferation on carbon nanotubes." Nano letters 6.3 (2006): 562-567.

-Gannon, Christopher J., et al. "Carbon nanotube‐enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field." Cancer: Interdisciplinary International Journal of the American Cancer Society 110.12 (2007): 2654-2665.

-Bianco, Alberto, Kostas Kostarelos, and Maurizio Prato. "Applications of carbon nanotubes in drug delivery." Current opinion in chemical biology 9.6 (2005): 674-679.

-Georgakilas, Vasilios, et al. "Broad family of carbon nanoallotropes: classification, chemistry, and applications of fullerenes, carbon dots, nanotubes, graphene, nanodiamonds, and combined superstructures." Chemical reviews 115.11 (2015): 4744-4822.

-Wang, Li-yu, et al. "Clinical application of carbon nanoparticles in curative resection for colorectal carcinoma." OncoTargets and therapy (2017): 5585-5589.

-Eslami, Majid, and Ali Ahmadi Peyghan. "DNA nucleobase interaction with graphene like BC3 nano-sheet based on density functional theory calculations." Thin Solid Films 589 (2015): 52-56.

-Eslami, Majid, Vahid Vahabi, and Ali Ahmadi Peyghan. "Sensing properties of BN nanotube toward carcinogenic 4-chloroaniline: a computational study." Physica E: Low-dimensional Systems and Nanostructures 76 (2016): 6-11.

-Cai, Hong-Ke, et al. "Colorectal cancer lymph node staining by activated carbon nanoparticles suspension in vivo or methylene blue in vitro." World Journal of Gastroenterology: WJG 18.42 (2012): 6148.

-Ahmad, Touqeer, et al. "Recent advances in combinatorial cancer therapy via multifunctionalized gold nanoparticles." Nanomedicine 15.12 (2020): 1221-1237.

-Lin, Duo, et al. "Colorectal cancer detection by gold nanoparticle based surface-enhanced Raman spectroscopy of blood serum and statistical analysis." Optics express 19.14 (2011): 13565-13577.

-Chen, Chao-Cheng, et al. "Evaluation of the biological behavior of a gold nanocore-encapsulated human serum albumin nanoparticle (Au@ HSANP) in a CT-26 tumor/ascites mouse model after intravenous/intraperitoneal administration." International Journal of Molecular Sciences 20.1 (2019): 217.

-Srivatsan, Avinash, et al. "Gold nanocage-photosensitizer conjugates for dual-modal image-guided enhanced photodynamic therapy." Theranostics 4.2 (2014): 163.

-Ji, Tianjiao, et al. "Tumor fibroblast specific activation of a hybrid ferritin nanocage‐based optical probe for tumor microenvironment imaging." Small 9.14 (2013): 2427-2431

-Li, Ya, et al. "Simultaneous electrochemical immunoassay of three liver cancer biomarkers using distinguishable redox probes as signal tags and gold nanoparticles coated carbon nanotubes as signal enhancers." Chemical communications 48.4 (2012): 537-539.

-Kannan, R. M., et al. "Emerging concepts in dendrimer‐based nanomedicine: from design principles to clinical applications." Journal of internal medicine 276.6 (2014): 579-617.

-Talanov, Vladimir S., et al. "Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging." Nano letters 6.7 (2006): 1459-1463.

-Tomalia, Donald A., L. A. Reyna, and S. Svenson. "Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging." (2007): 61-67.

-Mulligan, Richard C. "The basic science of gene therapy." Science 260.5110 (1993): 926-932.

-Sioud, Mouldy. "RNA interference: mechanisms, technical challenges, and therapeutic opportunities." RNA Interference: Challenges and Therapeutic Opportunities (2015): 1-15.

-Bulbake, Upendra, et al. "Liposomal formulations in clinical use: an updated review." Pharmaceutics 9.2 (2017): 12.

-Tang, Mary X., Carl T. Redemann, and Francis C. Szoka. "In vitro gene delivery by degraded polyamidoamine dendrimers." Bioconjugate chemistry 7.6 (1996): 703-714.

-Liang, Meng, et al. "Nanotechnology in diagnosis and therapy of gastrointestinal cancer." World Journal of Clinical Cases 10.16 (2022): 5146.

-Chen, Wenxue, et al. "Targeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshells." Nanomedicine 9.8 (2014): 1209-1222.

-England, Christopher G., et al. "Enhanced penetration into 3D cell culture using two and three layered gold nanoparticles." International journal of nanomedicine (2013): 3603-3617.

-Alagaratnam, Swethan, et al. "Mechano-growth Factor Expression in Colorectal Cancer Investigated With Fluorescent Gold Nanoparticles." Anticancer Research 39.4 (2019): 1705-1710.

-Biscaglia, Francesca, et al. "Gold nanoparticle aggregates functionalized with cyclic RGD peptides for targeting and imaging of colorectal cancer cells." ACS Applied Nano Materials 2.10 (2019): 6436-6444.

-Ravanshad, Rouhallah, et al. "Application of nanoparticles in cancer detection by Raman scattering based techniques." Nano reviews & experiments 9.1 (2018): 1373551.

-Fortina, Paolo, et al. "Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer." Trends in biotechnology 25.4 (2007): 145-152.

-Nataraj, Divya, et al. "Crosslinked chitosan films with controllable properties for commercial applications." International journal of biological macromolecules 120 (2018): 1256-1264.

-Nataraj, Divya, et al. "Crosslinked chitosan films with controllable properties for commercial applications." International journal of biological macromolecules 120 (2018): 1256-1264.

-Lee, Hyo-Jung, et al. "Controlled-release oral dosage forms containing nimodipine solid dispersion and hydrophilic carriers." Journal of Drug Delivery Science and Technology 37 (2017): 28-37.

-Hu, Anran, et al. "The properties of HPMC: PEO extended release hydrophilic matrices and their response to ionic environments." Pharmaceutical research 34 (2017): 941-956.

-Zhang, Wei, et al. "Injectable and body temperature sensitive hydrogels based on chitosan and hyaluronic acid for pH sensitive drug release." Carbohydrate polymers 186 (2018): 82-90.

-Martina, Marie-Sophie, et al. "Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging." Journal of the American Chemical Society 127.30 (2005): 10676-10685.

-Sweeney, Christina M., et al. "Optical properties of tipless gold nanopyramids." Small (Weinheim an der Bergstrasse, Germany) 7.14 (2011): 2032.

-Cheng, Gang, et al. "Functionalizable and ultrastable zwitterionic nanogels." Langmuir 26.10 (2010): 6883-6886.

-Huang, Gangliang, Yang Liu, and Ling Chen. "Chitosan and its derivatives as vehicles for drug delivery." Drug Delivery 24.2 (2017): 108-113.

-Chi, Jinhua, et al. "Antitumor evaluation of carboxymethyl chitosan based norcantharidin conjugates against gastric cancer as novel polymer therapeutics." International journal of biological macromolecules 136 (2019): 1-12.

-Kabanov, Alexander V., and Serguei V. Vinogradov. "Nanogels as pharmaceutical carriers: finite networks of infinite capabilities." Angewandte Chemie International Edition 48.30 (2009): 5418-5429.

-Senanayake, Thulani H., et al. "Application of activated nucleoside analogs for the treatment of drug-resistant tumors by oral delivery of nanogel-drug conjugates." Journal of Controlled Release 167.2 (2013): 200-209.

-Fan, Dai-Ming, Bing Xiao, and Yong-Quan Shi. "Novel cDNA fragment associated with gastric cancer drug resistance was screened out from a library by monoclonal antibody MGr1." World Journal of Gastroenterology 4.Suppl2 (1998): 143-143.




DOI: http://dx.doi.org/10.52155/ijpsat.v41.2.5784

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Maged Naser

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.